Mouse Tumor Necrosis Factor Ligand Superfamily Member 11 (TNFSF11) Protein

Product specifications

Proteins and Peptides

Tumor Necrosis Factor Ligand Superfamily Member 11 (TNFSF11)

E. coli

Mouse

Unconjugated

Molecular Weight: Calculated MW: 33.6 kDa  Observed MW: 33 kDa
Concentration: Prior to lyophilization: 200 µg/ml
Sequence Fragment: Ala73-Ile315
Tag: N-terminal His tag

Recombinant

> 90%

10 µg

50 µg

100 µg

200 µg

500 µg

Lyophilized Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/ml. Do not vortex.

WB, SDS-PAGE

Prior to lyophilization: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 0.01% Sarcosyl, 5% Trehalose.

Shipped within 5-7 working days.

Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.

No

O35235

Tumor necrosis factor ligand superfamily member 11,ODF,OPGL,sOdf,CD254,OPTB2,RANKL,TNLG6B,TRANCE,hRANKL2,Osteoclast differentiation factor,Osteoprotegerin ligand,Receptor activator of nuclear factor kappa-B ligand,

Protein TNFSF11

RUO

This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

TNFSF11, also known as RANKL (Receptor Activator of Nuclear Factor Kappa-Β Ligand), is a member of the tumor necrosis factor (TNF) superfamily. This protein is critical for bone metabolism, immune system regulation, and lymphoid tissue development. RANKL is primarily expressed on osteoblasts, T cells, and stromal cells, playing a major role in osteoclast differentiation and activation by binding to its receptor, RANK (Receptor Activator of Nuclear Factor Kappa-Β). Through the interaction between RANK and RANKL, this signaling pathway facilitates bone remodeling by controlling osteoclast-mediated bone resorption. RANKL is also vital in immune responses and is implicated in the formation of lymph nodes and mammary gland development. The physiological significance of TNFSF11 is underscored by its role in balancing bone formation and resorption. Disruptions in RANKL signaling can lead to metabolic bone disorders such as osteoporosis and osteopetrosis. RANKL is also an area of interest in cancer research, particularly in understanding bone metastasis in certain cancers, as well as autoimmune diseases where its role in immune regulation may contribute to chronic inflammation.

Related Products

Human TNFSF11/RANKL (Tumor necrosis factor ligand superfamily member 11) ELISA Kit

Ver Producto

Human TNFSF11/RANKL (Tumor necrosis factor ligand superfamily member 11) ELISA Kit

Ver Producto

Mouse TNFSF11/RANKL (Tumor necrosis factor ligand superfamily member 11) ELISA Kit

Ver Producto